Bitfarms [BITF] vs Morgan Stanley [MS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Bitfarms Ltd. wins in 3 metrics, Morgan Stanley wins in 13 metrics, with 0 ties. Morgan Stanley appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bitfarms Ltd. Morgan Stanley Better
P/E Ratio (TTM) -6.33 17.31 Morgan Stanley
Price-to-Book Ratio 4.89 2.97 Morgan Stanley
Debt-to-Equity Ratio 1.22 455.75 Bitfarms Ltd.
PEG Ratio -198.00 0.53 Morgan Stanley
EV/EBITDA -98.44 N/A N/A
Profit Margin (TTM) -8.25% 24.75% Morgan Stanley
Operating Margin (TTM) -85.77% 40.62% Morgan Stanley
EBITDA Margin (TTM) N/A 40.62% N/A
Return on Equity -37.21% 14.42% Morgan Stanley
Return on Assets (TTM) -16.08% 1.14% Morgan Stanley
Free Cash Flow (TTM) $-347.06M $-20.79B Bitfarms Ltd.
Dividend Yield N/A 2.15% N/A
1-Year Return 558.89% 65.29% Bitfarms Ltd.
Price-to-Sales Ratio (TTM) 8.68 4.15 Morgan Stanley
Enterprise Value $2.10B $225.65B Morgan Stanley
EV/Revenue Ratio 9.16 3.08 Morgan Stanley
Gross Profit Margin (TTM) -32.39% N/A N/A
Revenue per Share (TTM) $0 $47 Morgan Stanley
Earnings per Share (Diluted) $-0.38 $11.04 Morgan Stanley
Beta (Stock Volatility) N/A 1.18 N/A
Short % of Float 11.55% 0.00% Morgan Stanley

Bitfarms Ltd. vs Morgan Stanley Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bitfarms Ltd.-4.55%0.00%28.93%150.44%123.72%117.69%
Morgan Stanley1.84%2.70%13.23%40.00%22.61%19.84%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bitfarms Ltd.558.89%444.04%47.15%558.89%558.89%558.89%
Morgan Stanley65.29%142.98%154.54%745.67%837.54%275.57%

Performance & Financial Health Analysis: Bitfarms Ltd. vs Morgan Stanley

MetricBITFMS
Market Information
Market Cap i$1.99B$299.55B
Market Cap CategorySmall capMega cap
10 Day Avg. Volume i33,914,1736,501,123
90 Day Avg. Volume i33,438,8066,965,138
Last Close$5.66$217.98
52 Week Range$0.70 - $6.60$129.66 - $220.60
% from 52W High-14.24%-1.19%
All-Time High$10.00 (Dec 28, 2020)$220.60 (Jun 15, 2026)
% from All-Time High-43.40%-1.19%
Growth Metrics
Quarterly Revenue Growth-0.27%0.16%
Quarterly Earnings Growth-0.11%0.29%
Financial Health
Profit Margin (TTM) i-0.08%0.25%
Operating Margin (TTM) i-0.86%0.41%
Return on Equity (TTM) i-0.37%0.14%
Debt to Equity (MRQ) i1.22455.75
Cash & Liquidity
Book Value per Share (MRQ)$0.41$64.37
Cash per Share (MRQ)N/A$379.99
Operating Cash Flow (TTM) i$-348,225,000$-95,740,000,000
Levered Free Cash Flow (TTM) i$-208,514,000$16.25B
Dividends
Last 12-Month Dividend Yield iN/A2.15%
Last 12-Month Dividend iN/A$3.93

Valuation & Enterprise Metrics Analysis: Bitfarms Ltd. vs Morgan Stanley

MetricBITF (Apr 26, 2026)MS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-6.3317.31
Forward P/E i-198.0015.16
PEG Ratio i-198.000.53
Price to Sales (TTM) i8.684.15
Price to Book (MRQ) i4.892.97
Market Capitalization
Market Capitalization i$1.99B$299.55B
Enterprise Value i$2.10B$225.65B
Enterprise Value Metrics
Enterprise to Revenue i9.163.08
Enterprise to EBITDA i-98.44N/A
Risk & Other Metrics
Beta iN/A1.18
Book Value per Share (MRQ) i$0.41$64.37

Financial Statements Comparison: Bitfarms Ltd. vs Morgan Stanley

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBITF (2025)MS (2025)
Revenue/Sales i229.28M65.97B
Cost of Goods Sold i248.18MN/A
COGS % of Revenue i108.2%0.0%
Gross Profit i-18.90MN/A
Gross Margin i-8.2%0.0%
Research & Development iN/AN/A
Operating Income (EBIT) i-97.24MN/A
Operating Margin i-42.4%0.0%
EBITDA i-21.34MN/A
EBITDA Margin i-9.3%0.0%
Pre-Tax Income i-208.41M21.95B
Pre-Tax Income % of Revenue i-90.9%33.3%
Income Tax i101,0004.93B
Income Tax % of Revenue i0.0%7.5%
Net Income (Profit) i-208.51M17.03B
Profit Margin i-90.9%25.8%

Balance Sheet & Liquidity Metrics

MetricBITF (2025)MS (2025)
Cash & Equivalents i573.46M81.31B
Total Current Assets i826.47MN/A
Total Current Assets % of Revenue i360.5%0.0%
Total Current Liabilities i148.11MN/A
Total Current Liabilities % of Revenue i64.6%0.0%
Long-Term Debt i585.03M349.39B
Long-Term Debt % of Revenue i255.2%529.7%
Total Shareholders Equity i560.38M112.65B
Retained Earnings i-612.48M115.09B
Retained Earnings % of Revenue i-267.1%174.5%
Property, Plant & Equipment i367.24M20.00M

Cash Flow Statement Comparison

MetricBITF (2025)MS (2025)
Operating Cash Flow i-348.23M-95.74B
Operating Cash Flow % of Revenue i-151.9%-145.1%
Capital Expenditures i-85.90M-2.90B
Free Cash Flow i-347.06M-20.79B
FCF Margin i-151.4%-31.5%
Debt Repayment i-1.61M-99.39B
Common Stock Repurchase i-9.95M-5.84B

Short Interest & Institutional Ownership Analysis

MetricBITFMS
Shares Short i67.42M13,702
Short Ratio i2.290.00
Short % of Float i11.55%0.00%
Shares Outstanding i601.58M1.58B
Float Shares iN/A1.20B
% Held by Insiders i4.61%24.27%
% Held by Institutions i40.00%63.01%
% Held by Public i55.39%12.72%

Dividend Analysis & Yield Comparison: Bitfarms Ltd. vs Morgan Stanley

MetricBITFMS
Last 12-Month Dividend iN/A$3.93
Last 12-Month Dividend Yield iN/A2.15%
3-Year Avg Annual Dividend iN/A$3.63
3-Year Avg Dividend Yield iN/A0.83%
3-Year Total Dividends iN/A$10.90
Ex-Dividend DateN/AJan 30, 2026